TickerGuard
Buy Day today: Neutral (47) Mixed market breadth · no major macro event
QURE

Uniqure NV

Healthcare · Biotechnology

23.10$ +0.3% vs. previous close Closing price · As of: Oct 7, 2026

Statements

Balance Sheet

Uniqure NV (QURE) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 825 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet QURE
Line item 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
30 7.5 7.4 54 116 265 190 209 274 449 340 809 705 832 557 825
25 2.8 1.5 38 70 229 144 163 237 384 259 628 477 652 390 656
24 1.4 0.3 33 65 223 132 159 235 378 245 556 228 241 159 80
24 1.4 0.3 33 65 223 132 159 235 378 245 556 353 618 368 623
0.9 1.4 1.1 3.6 4.2 4.1 9.2 1.6 0.2 0.9 6.6 59 102 4.2 5.9 5.9
0.0 – -1.1 1.2 0.2 0.5 1.0 1.1 1.1 4.7 4.3 11 6.9 12 0.0 –
– – 1.6 3.6 24 26 36 34 29 29 32 44 83 – – –
– – – – 1.6 0.5 0.5 0.5 0.5 0.5 0.5 28 26 26 22 25
3.9 3.5 4.3 11 20 7.9 8.3 8.8 5.2 5.4 3.4 63 59 60 71 73
12 11 8.0 46 64 134 127 119 94 126 96 213 229 624 563 626
5.6 4.8 7.4 14 15 27 23 19 20 32 27 37 76 74 40 63
– – – 1.2 0.8 5.6 0.6 1.8 8.0 5.9 5.5 5.8 8.4 8.3 3.6 3.9
2.1 2.3 0.8 4.8 3.9 4.1 5.5 2.9 3.8 5.7 3.8 2.5 11 6.6 7.2 5.2
– – 0.6 9.1 20 15 20 20 35 36 36 101 103 102 51 50
18 -3.4 -0.6 7.7 52 131 64 90 180 323 244 596 476 208 -6.8 199
-117 -137 -155 -199 -220 -276 -396 -467 -536 -660 -785 -455 -582 -890 -1,130 -1,329
– 18 18 18 17 22 25 27 36 40 44 47 47 48 49 58

Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?